Skip to main content
Tatva Chintan Pharma Chem Limited logo

Tatva Chintan Pharma Chem Limited — Investor Relations & Filings

Ticker · TATVA ISIN · INE0GK401011 LEI · 335800I28VDPT9WEFU68 BSE.NS Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS TATVA

About Tatva Chintan Pharma Chem Limited

https://www.tatvachintan.com/

Tatva Chintan Pharma Chem Limited specializes in the manufacturing of Structure Directing Agents (SDAs), Phase Transfer Catalysts (PTCs), and electrolyte salts for supercapacitor batteries. The company also produces a diverse range of pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). Its SDAs are essential for the synthesis of zeolites, which find applications in automotive emission control and petrochemical refining. By integrating green chemistry principles into its manufacturing processes, the company provides high-purity products for global markets. Its core competencies include complex chemical synthesis and dedicated research and development, focusing on sustainable solutions for the energy storage, environmental, and life sciences sectors.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 83% confidence The document is a declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, filed with stock exchanges to confirm that no encumbrance was made during the financial year. This is a compliance/regulatory announcement rather than an annual report, earnings release, or shareholding threshold notification. It falls under general regulatory filings.
2026-05-29 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a declaration under SEBI regulation 31(4) regarding non-encumbrance of promoter shares for the year ended March 31, 2026. It is a compliance filing to stock exchanges under Indian takeover/SEBI LODR rules and does not provide financial results, management discussion, or an attached report. This type of regulatory/compliance announcement falls under the fallback category “Regulatory Filings (RNS).”
2026-05-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a formal compliance declaration submitted to stock exchanges under SEBI’s Substantial Acquisition of Shares and Takeovers Regulations (Regulation 31(4)) stating no encumbrance of shares by promoters. It is not a financial report, earnings release, or management discussion; rather, it is a regulatory compliance announcement. Therefore it falls under the general ‘Regulatory Filings’ category.
2026-05-19 English
Transcript of the earnings call held on 16 May 2026 post announcement of the financial results of the Company for the quarter and financial year ended 31 March 2026.
Call Transcript Classification · 99% confidence The document is a transcript of the company’s Q4 FY26 earnings conference call, including opening remarks, management comments, and Q&A, submitted under Regulation 30 of SEBI LODR. This aligns directly with the definition of a Call Transcript (CT).
2026-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on May 16, 2026, discussing the financial results for the quarter and financial year ended March 31, 2026. It includes management commentary, financial highlights, segment-wise performance, and a Q&A session. The presence of a full transcript with detailed discussion and Q&A clearly identifies this as a Call Transcript (CT). The document is not a brief announcement or summary, nor is it a formal report like an Annual Report or Interim Report. It is also not an announcement of the transcript but the transcript itself. Therefore, the correct classification is Call Transcript (CT).
2026-05-19 English
Submission of Annual Secretarial Compliance Report for the financial year ended 31 March 2026 (2025-2026).
Regulatory Filings Classification · 90% confidence The document is a submission to stock exchanges of the company’s Annual Secretarial Compliance Report under SEBI LODR Regulation 24A for the financial year ended 31 March 2026. It is not a financial report (Annual Report, Interim Report, or Earnings Release), nor is it a change-in-management, capital update, or other specialized filing. It is a regulatory compliance certificate/circular furnished to the exchanges, making it a general "Regulatory Filing" (RNS).
2026-05-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.